Pathogen News and Research RSS Feed - Pathogen News and Research

Study shows pathogens can survive in dry foods for long periods of time

Study shows pathogens can survive in dry foods for long periods of time

Researchers at the University of Georgia found that pathogens, like salmonella, can survive for at least six months in cookies and crackers. [More]
New easy-to-use computer program can quickly identify drug-resistant infections

New easy-to-use computer program can quickly identify drug-resistant infections

Scientists have developed an easy-to-use computer program that can quickly analyse bacterial DNA from a patient's infection and predict which antibiotics will work, and which will fail due to drug resistance. The software is currently being trialled in three UK hospitals to see whether it could help speed up diagnosis of drug-resistant infections and enable doctors to better target the prescription of antibiotics. [More]
Australian researchers develop new technique to combat chronic bacterial infections in hospitals

Australian researchers develop new technique to combat chronic bacterial infections in hospitals

One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found. [More]
Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

Luminex Corporation today announced that it has received FDA clearance for its NxTAG Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae and Mycoplasma pneumonia. [More]
New vaccine shows promise against Middle East respiratory syndrome in dromedary camels

New vaccine shows promise against Middle East respiratory syndrome in dromedary camels

An international research project with the involvement of Universitat Autònoma de Barcelona and the Animal Health Research Centre (IRTA-CReSA), has designed a vaccine shown to be effective in protecting dromedaries against the coronavirus (CoV) that causes Middle East respiratory syndrome (MERS). [More]
Findings show promising evidence for creating broad-spectrum antiviral

Findings show promising evidence for creating broad-spectrum antiviral

UW researchers working in collaboration with Kineta Inc. and the University of Texas at Galveston have shown that making a drug-like molecule to turn on innate immunity can induce genes to control infection in several -known viruses. [More]
New discovery could open door to potential treatment for West Nile virus and Dengue virus infections

New discovery could open door to potential treatment for West Nile virus and Dengue virus infections

A new discovery from the University of Alberta's Faculty of Medicine & Dentistry could open the door to one day treat or prevent diseases caused by West Nile virus and Dengue virus infections. [More]
Louisville researchers move closer to potential treatment for gum disease

Louisville researchers move closer to potential treatment for gum disease

University of Louisville researchers recently received a patent on a synthetic biochemical compound and its variants, moving science closer to a treatment for gum disease. This discovery could lead to the formulation of a mouth rinse or tooth varnish to prevent the pathogen, P. gingivalis from colonizing in the mouth and establishing itself orally. [More]
U of T researchers find another clue in understanding the cause of MS

U of T researchers find another clue in understanding the cause of MS

Researchers at the University of Toronto have found another clue in understanding the cause of what drives Multiple Sclerosis (MS) disease. Their findings were published today in Immunity. [More]
New rapid test can detect malaria parasites, viruses and biomarkers

New rapid test can detect malaria parasites, viruses and biomarkers

Nothing could be simpler: a drop of blood is placed on a special carrier substance; after a wait of a few minutes, the slide is placed on a device that emits polarised light thanks to an inexpensive polarisation filter. It is covered with a lid containing a second polarisation filter, which blocks the light from all materials except crystalline or materials with directional properties. [More]
U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

The United States has sufficient capacity for treating another outbreak of the Ebola virus, but financial, staffing and resource challenges remain a hurdle for many hospitals and health systems attempting to maintain dedicated treatment centers for highly infectious diseases, according to new study released today. [More]
Abbott, UCSF identify human pegivirus 2 among some patients with hepatitis C

Abbott, UCSF identify human pegivirus 2 among some patients with hepatitis C

Abbott and University of California San Francisco published research identifying a newly discovered human virus, known as human pegivirus 2 (HPgV-2), and proving it is found among some patients with hepatitis C (HCV). [More]
Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

Bacteriophage therapy: an alternative to antibiotics? An interview Professor Clokie

A phage is a virus that infects a bacterium. People often get very confused about what the difference is between a virus and a bacterium. A virus, like a bacterium, is also a microorganism, but unlike bacteria, it needs to have a host to be able to replicate and propagate. [More]
Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics, Inc.), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen specific diseases, announced positive topline results from the first Phase 2a study of SYN-004, the Company's candidate designed to protect the gut microbiome from the unintended effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). [More]
Researchers aiming to improve accuracy of current diagnostics for Leishmania infantum kinetoplast

Researchers aiming to improve accuracy of current diagnostics for Leishmania infantum kinetoplast

In an article published in Small, researchers successfully applied a new qualitative and quantitative method for the detection of a DNA sequence characteristic of Leishmania infantum kinetoplast, a frequent parasite in veterinary that affects humans too. [More]
WPI researchers awarded $1.3 million NIH grant to study use of copper to battle bacterial invader

WPI researchers awarded $1.3 million NIH grant to study use of copper to battle bacterial invader

Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader. [More]
TGen receives 2015 Regents' Award for Outstanding Service to Higher Education

TGen receives 2015 Regents' Award for Outstanding Service to Higher Education

The Arizona Board of Regents presented the Translational Genomics Research Institute with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University. [More]
U of T researchers discover mysterious fungus that defends against neighbouring bacteria

U of T researchers discover mysterious fungus that defends against neighbouring bacteria

Researchers at the University of Toronto examined fungi in the mucus of patients with cystic fibrosis and discovered how one particularly cunning fungal species has evolved to defend itself against neighbouring bacteria. [More]
Research findings may lead to potential therapeutic target for treating inflammatory bowel diseases

Research findings may lead to potential therapeutic target for treating inflammatory bowel diseases

UT Southwestern Medical Center researchers have shown that a pathogen-sensing molecule plays a vital role in keeping gastrointestinal (GI) systems healthy. [More]
Birmingham researchers identify how Salmonella infections can lead to life-threatening thrombosis

Birmingham researchers identify how Salmonella infections can lead to life-threatening thrombosis

Researchers from the University of Birmingham have, for the first time, identified how Salmonella infections that have spread to our blood and organs can lead to life-threatening thrombosis. [More]
Advertisement
Advertisement